Loading insider details...
Beta
Latest Form 4 (May 29, 2026): Grant/Award of 1,800,000 BCLI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 29, 2026 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 1,800,000 | n/a |
| Jan 3, 2025 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 120,000 | n/a |
| Oct 2, 2024 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Purchase | 22,000 | $5.0K |
| Jun 3, 2024 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 15,000 | $7.8K |
| May 23, 2024 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 25,000 | $14.5K |
| May 14, 2024 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 20,000 | $9.3K |
| May 7, 2024 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 66,300 | $24.8K |
| May 7, 2024 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 135,000 | $50.7K |
| Apr 25, 2024 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 15,000 | $7.8K |
| Apr 19, 2024 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 130,000 | $70.9K |